Your browser doesn't support javascript.
loading
[Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in MDS-EB and AML-MRC].
Liu, J; Jia, J S; Gong, L Z; Lu, S Y; Zhu, H H; Huang, X J; Jiang, H.
Affiliation
  • Liu J; Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
Zhonghua Xue Ye Xue Za Zhi ; 39(9): 734-738, 2018 Sep 14.
Article in Zh | MEDLINE | ID: mdl-30369183
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2018 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2018 Document type: Article Affiliation country: China Country of publication: China